In addition, future exploration could involve further detecting the mutated tumor genomes (PTEN, TP53, EGFR, TTN, and MUC) that are highly correlated with TMB in additional samples or inducing mutations in model cells through molecular biotechnology. The gene discussed is TP53; the disease is neoplasm.